IL201907A0 - Elimination of interference in immunoassays caused by anti-carbohydrate antibodies - Google Patents

Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Info

Publication number: IL201907A0
Authority: IL; Israel
Prior art keywords: immunoassays; elimination; interference; caused; carbohydrate antibodies
Prior art date: 2007-05-07

Application number

IL201907A

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-07

Filing date

2009-11-03

Publication date

2010-06-16

2009-11-03 Application filed by Wyeth Llc filed Critical Wyeth Llc

2010-06-16 Publication of IL201907A0 publication Critical patent/IL201907A0/en

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL201907A 2007-05-07 2009-11-03 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies IL201907A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92814407P	2007-05-07	2007-05-07
US92843807P	2007-05-08	2007-05-08
PCT/US2008/062739 WO2008137885A1 (en)	2007-05-07	2008-05-06	Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Publications (1)

Publication Number	Publication Date
IL201907A0 true IL201907A0 (en)	2010-06-16

Family

ID=39666131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL201907A IL201907A0 (en)	2007-05-07	2009-11-03	Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Country Status (11)

Country	Link
EP (1)	EP2142925A1 (en)
JP (1)	JP2010527005A (en)
KR (1)	KR20100029083A (en)
CN (1)	CN101680880A (en)
AU (1)	AU2008247352A1 (en)
BR (1)	BRPI0811290A2 (en)
CA (1)	CA2686206A1 (en)
IL (1)	IL201907A0 (en)
MX (2)	MX2009012044A (en)
RU (1)	RU2009141159A (en)
WO (1)	WO2008137885A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2011247610A1 (en)	2010-04-29	2012-12-13	Therading Sa	Methods for detecting antibodies
EP3105592B1 (en)	2014-02-11	2018-10-17	Genzyme Corporation	Assays for detecting the presence or amount of an anti-drug antibody
EP3176580A1 (en) *	2015-12-01	2017-06-07	Roche Diagnostics GmbH	Method for reduction of interferences in immunoassays
GB201522839D0 (en) *	2015-12-23	2016-02-03	Randox Lab Ltd And Randox Teoranta	Method
CA3029133C (en) *	2016-06-23	2024-04-30	Ablynx N.V.	Improved pharmacokinetic assays for immunoglobulin single variable domains
CN108535490A (en) *	2017-03-06	2018-09-14	苏州和锐生物科技有限公司	Biological agent blood concentration detection method and reagent
MA53130A (en)	2018-07-10	2021-05-19	Regeneron Pharma	TARGET DRUG INTERFERENCE MITIGATION METHODS IN AN IMMUNOLOGICAL ASSAY OF ANTI-DRUG ANTIBODIES (ADA)
CN113514632B (en) *	2021-04-20	2024-06-25	中国科学技术大学	Microcantilever immunosensing method based on nanoantibodies
EP4513190A4 (en) *	2022-04-19	2025-11-19	Sungkwang Medical Found	METHOD FOR PREDICTING THE RESPONDENCE TO TREATMENT WITH BIOLOGICAL DRUGS BY MEASURING THE CONCENTRATION OF ANTI-DRUG ANTIBODIES IN THE BLOOD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5705353A (en) *	1995-06-07	1998-01-06	Beckman Instruments, Inc.	Method of reducing interferences in assays
US5856106A (en) *	1995-11-01	1999-01-05	Biotransplant, Inc.	Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies

2008
- 2008-05-06 RU RU2009141159/15A patent/RU2009141159A/en not_active Application Discontinuation
- 2008-05-06 JP JP2010507595A patent/JP2010527005A/en not_active Withdrawn
- 2008-05-06 MX MX2009012044A patent/MX2009012044A/en not_active Application Discontinuation
- 2008-05-06 CA CA002686206A patent/CA2686206A1/en not_active Abandoned
- 2008-05-06 AU AU2008247352A patent/AU2008247352A1/en not_active Abandoned
- 2008-05-06 WO PCT/US2008/062739 patent/WO2008137885A1/en not_active Ceased
- 2008-05-06 BR BRPI0811290-8A2A patent/BRPI0811290A2/en not_active Application Discontinuation
- 2008-05-06 MX MX2009012048A patent/MX2009012048A/en unknown
- 2008-05-06 EP EP08755078A patent/EP2142925A1/en not_active Withdrawn
- 2008-05-06 CN CN200880015303A patent/CN101680880A/en active Pending
- 2008-05-06 KR KR1020097025396A patent/KR20100029083A/en not_active Withdrawn
2009
- 2009-11-03 IL IL201907A patent/IL201907A0/en unknown

Also Published As

Publication number	Publication date
JP2010527005A (en)	2010-08-05
AU2008247352A1 (en)	2008-11-13
WO2008137885A1 (en)	2008-11-13
MX2009012044A (en)	2009-11-18
CA2686206A1 (en)	2008-11-13
CN101680880A (en)	2010-03-24
KR20100029083A (en)	2010-03-15
MX2009012048A (en)	2010-02-24
EP2142925A1 (en)	2010-01-13
RU2009141159A (en)	2011-06-20
BRPI0811290A2 (en)	2014-10-21

Publication	Publication Date	Title
HRP20181616T1 (en)	2018-12-14	Fully human anti-vap-1 monoclonal antibodies
AP3371A (en)	2015-07-31	Anti-IGF antibodies
EP2331579A4 (en)	2013-01-23	Monoclonal antibodies
SG10201601279SA (en)	2016-03-30	Monoclonal Antibody STRO-4
IL200437A0 (en)	2010-04-29	Anti-sclerostin antibodies
IL218724A0 (en)	2012-06-28	Endoglin antibodies
IL201907A0 (en)	2010-06-16	Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
SI2195026T1 (en)	2014-04-30	Anti-sclerostin antibodies
GB0708002D0 (en)	2007-06-06	Antibodies
SG10201605394SA (en)	2016-08-30	Modified Antibody Constant Region
IL200168A0 (en)	2010-04-15	Monoclonal anti-cxcl13 antibodies
EP2222871A4 (en)	2012-01-25	Methods of performing ultra-sensitive immunoassays
SI2200700T1 (en)	2016-04-29	Novel antibodies
IL201983A (en)	2015-03-31	Anti-pan nrpa antibodies
GB0718737D0 (en)	2007-11-07	Antibodies
GB0702888D0 (en)	2007-03-28	Novel Antibodies
IL212900A0 (en)	2011-07-31	Isoform specific anti-her4 antibodies
ZA201103941B (en)	2012-11-28	Anti-ferroportin 1 monoclonal antibodies and uses thereof
SI2184605T1 (en)	2016-05-31	Dual-recognition immunoassay for the detection of antibodies
ZA200907833B (en)	2010-07-28	Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
GB0724185D0 (en)	2008-01-23	Antibodies